Promedior's Series C Round

Promedior raised a round of funding on March 17, 2010.

Promedior is a clinical stage immunotherapy company pioneering the development of targeted therapeutics to treat diseases involving fibrosis. Fibrosis occurs when healthy tissue is replaced with exces…

Articles about Promedior's Series C Round: